A Novel Synthesis of Macitentan, an Endothelin Receptor Antagonist

被引：3
|
作者：
Nami, Majid [1 ]
Sovari, Sara Nasiri [2 ]
Haghighatnia, Yaghoub [2 ]
Dabiri, Minoo [1 ]
Salehi, Peyman [3 ]
机构：
[1] Shahid Beheshti Univ, Fac Chem, Tehran 1983963113, Iran
[2] Hasti Aria Shimi Co, Dept Res & Dev, Tehran 1463745481, Iran
[3] Shahid Beheshti Univ, Dept Phytochem, Med Plants & Drugs Res Inst, GC Evin, Tehran 1983963113, Iran
来源：
ORGANIC PREPARATIONS AND PROCEDURES INTERNATIONAL | 2017年 / 49卷 / 03期
关键词：
PULMONARY ARTERIAL-HYPERTENSION; THERAPY; SITAXSENTAN; BOSENTAN;
D O I：
10.1080/00304948.2017.1320921
中图分类号：
O62 [有机化学];
学科分类号：
070303 ; 081704 ;
摘要：
[No abstract available]
引用
收藏
页码：258 / 264
页数：7
相关论文
共 50 条
  • [31] The Endothelin Receptor Antagonist Macitentan Attenuates Vasoconstrictive Effects of Endothelin-1 following Intravitreal Administration in Rodents
    Krishnamoorthy, Raghu R.
    Zhang, Wei
    Chavala, Sai
    Stankowska, Dorota L.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2019, 60 (09)
  • [32] New horizons for the use of the second generation of endothelin receptor antagonist macitentan in patients with pulmonary hypertension
    Martynyuk, T., V
    Nakonechnikov, S. N.
    Chazova, I. Ye
    TERAPEVTICHESKII ARKHIV, 2018, 90 (04) : 72 - 80
  • [33] Treatment of pulmonary arterial hypertension with the dual endothelin receptor antagonist macitentan: clinical evidence and experience
    Belge, Catharina
    Delcroix, Marion
    THERAPEUTIC ADVANCES IN RESPIRATORY DISEASE, 2019, 13
  • [34] Antivascular Therapy for Multidrug-Resistant Ovarian Tumors by Macitentan, a Dual Endothelin Receptor Antagonist
    Kim, Sun-Jin
    Kim, Jang Seong
    Kim, Seung Wook
    Yun, Seok Joong
    He, Junqin
    Brantley, Emily
    Fan, Dominic
    Strickner, Panja
    Lehembre, Francois
    Regenass, Urs
    Fidler, Isaiah J.
    TRANSLATIONAL ONCOLOGY, 2012, 5 (01): : 39 - 47
  • [35] PHARMACOKINETICS, TOLERABILITY, AND SAFETY OF THE DUAL ENDOTHELIN RECEPTOR ANTAGONIST MACITENTAN IN JAPANESE AND CAUCASIAN HEALTHY SUBJECTS
    Bruderer, S.
    Marjason, J.
    Sidharta, P.
    Dingemanse, J.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2011, 89 : S83 - S83
  • [36] Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
    Bruderer, Shirin
    Aeaenismaa, Paeivi
    Homery, Marie-Claude
    Haeusler, Stephanie
    Landskroner, Kyle
    Sidharta, Patricia N.
    Treiber, Alexander
    Dingemanse, Jasper
    AAPS JOURNAL, 2012, 14 (01): : 68 - 78
  • [37] Pulmonary arterial hypertension outcomes upon endothelin-1 receptor antagonist switch to macitentan
    Tynan, Timothy
    Hird, Kathryn
    Hannon, Tara
    Gabbay, Eli
    JOURNAL OF INTERNATIONAL MEDICAL RESEARCH, 2019, 47 (05) : 2177 - 2186
  • [38] Therapeutic Effect Of Macitentan, A Novel Dual Endothelin Receptor Antagonist, On Right Ventricular Structure And Function In Pulmonary Arterial Hypertensive Rats
    Vercauteren, M.
    Hadana, H.
    Cattaneo, C.
    Kramberg, M.
    Bortolamiol, C.
    Rey, M.
    Renault, B.
    Bauer, Y.
    Steiner, P.
    Iglarz, M.
    Vezzali, E.
    Weber, E.
    Studer, R.
    Strasser, D.
    Nayler, O.
    Hess, P.
    Clozel, M.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2015, 191
  • [39] Aprocitentan: A Novel Endothelin Receptor Antagonist for Hypertension
    Nguyen, Timothy
    Wong, Elaine
    JNP- THE JOURNAL FOR NURSE PRACTITIONERS, 2024, 20 (09):
  • [40] Effect of Cyclosporine and Rifampin on the Pharmacokinetics of Macitentan, a Tissue-Targeting Dual Endothelin Receptor Antagonist
    Shirin Bruderer
    Päivi Äänismaa
    Marie-Claude Homery
    Stephanie Häusler
    Kyle Landskroner
    Patricia N. Sidharta
    Alexander Treiber
    Jasper Dingemanse
    The AAPS Journal, 2012, 14 : 68 - 78
12345